arXiv:2606. 05139v1 Announce Type: new Abstract: The rapid advancement of high-throughput sequencing has led to large, high-dimensional omics datasets.
By Luca Thale-Bombien, Jan Ewald, Ralf K\"onig, Aaron Klein
arXiv:2607. 10196v1 Announce Type: new Abstract: Access to sufficiently large biomedical datasets remains a major obstacle for machine learning in Raman spectroscopy-based diagnostics.
By Andrei Iu\c{s}an, Iulian Vasile, Daria Voiculescu, Ion Petre, Andrei P\u{a}un, Bogdan Oancea, Mihaela P\u{a}un
arXiv:2605. 31014v2 Announce Type: replace Abstract: Multi-omics data provide complementary molecular characterizations of disease phenotypes and play an important role in disease diagnosis and subtype classification in precision medicine.
By Nan Mu, Yangfan Xiao, Ling Wang, Xiaoning Li, Yue Kang, Chen Zhao
arXiv:2506. 01486v2 Announce Type: replace Abstract: Data imbalance persists as a pervasive challenge in regression tasks, introducing bias in model performance and undermining predictive reliability.
By Jelke Wibbeke, Sebastian Rohjans, Andreas Rauh
arXiv:2505. 13518v3 Announce Type: replace-cross Abstract: Imbalanced datasets, where one class significantly outnumbers others, remain a persistent challenge in machine learning, often biasing predictions toward the majority class and degrading classifier performance.
By Behnam Yousefimehr, Mehdi Ghatee, Javad Fazli, Shervin Ghaffari, Zahra Rafei, Mohammad Amin Seifi, Sajed Tavakoli, Abolfazl Nikahd, Mahdi Razi Gandomani, Alireza Orouji, Ramtin Mahmoudi Kashani, Sarina Heshmati, Negin Sadat Mousavi
arXiv:2606. 07141v1 Announce Type: cross Abstract: Language models trained for clinical disease inference are trained on patient data, which may include sensitive and private information, and data owners may request the removal of their data from a trained model due to privacy or copyright concerns.
By Anurag Sharma, Sai Teja Chunchu, Prasenjit Mitra, Sandipan Sikdar, Koustav Rudra
arXiv:2607. 09884v1 Announce Type: cross Abstract: Multimodal medical models often degrade when inputs are missing, a common scenario in real-world clinical workflows.
By Nusrat Binta Nizam, Fengbei Liu, Sunwoo Kwak, Minh Nguyen, Ruining Deng, Mert R. Sabuncu
The paper presents a newly curated, multi-center, multi-modal, and longitudinal lung cancer dataset comprising 1,365 patients with whole-slide images, CT scans, PET scans, structured clinical data, transcriptomics, and follow-up information. The dataset features substantial, non-uniform missingness across modalities, making it ideal for evaluating robust multi-modal fusion strategies. Benchmarks on 12‑month overall survival, disease‑specific survival, and longitudinal hazard prediction demonstrate that integrating complementary modalities consistently outperforms uni-modal approaches, even under severe missing data.
By Rita Cordeiro Mendes, Maria Rita Fonseca Verdelho, Carlos Santiago, Catarina Barata
arXiv:2512. 17678v2 Announce Type: replace-cross Abstract: Selecting compact and informative gene subsets from single-cell transcriptomic data is essential for biomarker discovery, improving interpretability, and cost-effective profiling.
By Daphn\'e Chopard, Jorge da Silva Gon\c{c}alves, Irene Cannistraci, Thomas M. Sutter, Julia E. Vogt
arXiv:2608. 13939v1 Announce Type: cross Abstract: Ultrasound is the primary imaging modality for assessing thyroid nodules, and the ACR TI-RADS framework standardizes diagnosis through five ultrasound feature categories that are aggregated into five risk levels (TR1-TR5).
By Bingxin Yu, Xueli Wang, Jerry Zhou, Wenyan Wang, Li Wen, Lan Huang, Xin Feng, Fengfeng Zhou, Kewei Li
arXiv:2407.03463v2 Announce Type: replace-cross
Abstract: In the realm of self-supervised learning (SSL), conventional wisdom has gravitated towards the utility of massive, general domain datasets fo...
By Jes\'us M Rodr\'iguez-de-Vera, Imanol G Estepa, Ignacio Saras\'ua, Bhalaji Nagarajan, Petia Radeva
arXiv:2606. 25770v1 Announce Type: new Abstract: Data scarcity is a major bottleneck in medical Multiple Instance Learning (MIL), especially for rare diseases or expensive modalities.
By Muhammed Furkan Dasdelen, Fatih Ozlugedik, Anastasia Litinetskaya, Nassir Navab, Carsten Marr, Ario Sadafi